Further analysis indicated that lenvatinib upregulated the levels of GSDME in HCC cells and activated the N-terminal protein levels of GSDME, thereby inducing pyroptosis and promoting the death of liver cancer cells [36] (Table 2). This evidence concerns the gene GSDME and hepatocellular carcinoma.